Correlations Between Clinical Patterns and Causes of Erythema Multiforme Majus, Stevens-Johnson Syndrome, and Toxic Epidermal Necrolysis
Top Cited Papers
Open Access
- 1 August 2002
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 138 (8), 1019-1024
- https://doi.org/10.1001/archderm.138.8.1019
Abstract
UNTIL RECENTLY, most textbooks of medicine considered erythema multiforme to be a spectrum of disorders that included erythema multiforme majus (EMM), Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis (TEN). A few years ago, an international group of investigators began a large case-control study, the Severe Cutaneous Adverse Reactions (SCAR) study, to determine the risk factors for EMM, SJS, and TEN. As a preliminary step, participants had to agree on definition and classification criteria. After reviewing several hundred photographs of historic cases, they agreed that it was usually possible to distinguish 2 different clinical groups within cases that had been labeled EMM or SJS.1 In both groups mucous membrane erosions were present, but the individual pattern and distribution of the skin lesions differed. The first group was characterized by acrally distributed targets typical enough to fit the original description of erythema multiforme.2 In the second group, including patients with SJS and TEN, the skin lesions were widespread and consisted of blisters arising on erythematous or purpuric macules, closely resembling the original description of SJS.3 Implicit to this new classification were the hypotheses that (1) EMM is different from SJS and (2) SJS and TEN are only severity variants of a single entity.Keywords
This publication has 8 references indexed in Scilit:
- A double-blind, placebo-controlled trial of continuous acyclovir therapy in recurrent erythema multiformeBritish Journal of Dermatology, 2006
- Herpes Simplex Virus Associated Erythema Multiforme (HAEM) is Mechanistically Distinct from Drug-Induced Erythema Multiforme: Interferon-γ is Expressed in HAEM Lesions and Tumor Necrosis Factor-α in Drug-Induced Erythema Multiforme LesionsJournal of Investigative Dermatology, 1999
- Erythema Multiforme and Toxic Epidermal Necrolysis: A Comparative StudyThe American Journal of Dermatopathology, 1997
- Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990–1992): Structure and results of a population-based registryJournal of Clinical Epidemiology, 1996
- Medication Use and the Risk of Stevens–Johnson Syndrome or Toxic Epidermal NecrolysisNew England Journal of Medicine, 1995
- An international collaborative case-control study of severe cutaneous adverse reactions (SCAR). Design and methodsJournal of Clinical Epidemiology, 1995
- Requiem for toxic epidermal necrolysisBritish Journal of Dermatology, 1990
- Acute disseminated epidermal necrosis types 1, 2, and 3: Study of sixty casesJournal of the American Academy of Dermatology, 1985